ROCK2 and Parkinson disease: Therefore, future studies characterizing EVs in PD are crucial for identifying novel therapeutic targets by further understanding the specific protein and nucleic acid cargo carried within these vesicles, particularly focusing on the role of ROCK2 inhibitors in restoring mitophagy and mitochondrial function.